Sergey Vakula
Portfolio
Sergan Management
As a strategist for global business development, acquisitions, and partnerships, I provide expert advice to drive growth. Here are some of my key contributions: • I have created and refined business practices that effectively manage projects and corporate concerns across various industries, including pharma, fintech, travel, real estate, and more. • I specialize in managing complex and multi-disciplinary projects, working with a range of clients from single family offices to corporations and individuals. My expertise includes company valuations, financial and scientific due diligence, and fundraising. • I offer a full range of multi-family office services. • One of my notable achievements includes designing the concept and developing the strategy for a multiuse hospitality and residential real estate project spanning over approximately 200 hectares. - In summary, I bring a wealth of experience and a diverse skill set to provide strategic guidance for business growth and development across various industries.
AVD
- I have provided an extensive range of multi-family office services, developed business strategies, and established corporate objectives for a select group of high net-worth clients on the Forbes Global List. Here are some of my notable achievements: • I have created multiple family offices and operational companies in Monaco (SAM), designing their corporate strategies for success. • I also conceptualized a hospitality and residential real estate compound in the central Mediterranean, including the utilization of the territory and a stepwise development strategy. - My expertise in family office services and corporate strategy has enabled me to offer tailored solutions to meet the unique needs of high net-worth clients. Additionally, my innovative approach to real estate development has led to the creation of exceptional properties in desirable locations.
Biotech and Pharma Investments
Key Contributions: • Controlled and managed portfolio of direct investments with budget of more than USD 120M. • Coordinated all activities of biopharma companies by efficiently monitoring and administering all functions. • Ensured cross-company interaction and exchange of ideas, along with streamlining the entirety of operations. • Analysed a multitude of investment proposals and performed due diligence on some select companies.